Omega-3s are looking good for healthy eye function, thanks to a new study in the Journal of Lipid Research. Researchers at the University of Utah investigated the relationships between ocular levels of very long chain fatty acids and long chain fatty acids, and age-related macular degeneration (AMD). Using human donor eyes and gas chromatography and mass spectrometry methods to detect fatty acid presence, the researchers made several key findings related to omega-3s.
Omega-3s are looking good for healthy eye function, thanks to a new study in the Journal of Lipid Research.
Researchers at the University of Utah investigated the relationships between ocular levels of very long chain fatty acids and long chain fatty acids, and age-related macular degeneration (AMD). Using human donor eyes and gas chromatography and mass spectrometry methods to detect fatty acid presence, the researchers made several key findings related to omega-3s.
Donor eyes were dissected within 26 hours of death and categorized into four groups: young, middle-aged, old, and age-matched AMD.
Concerning docosahexaenoic acid (DHA), an omega-3 commonly marketed in algal and fish oils, the researchers found that DHA and adrenic acid (AA; an omega-6) levels in retinal tissues significantly decreased in AMD eyes compared to old, non-AMD eyes. Furthermore, AA/DHA and omega-6/omega-3 ratios significantly increased in the AMD group compared to the old group. In the middle-aged group, ratios were detected as significantly lower.
The researchers also reported that 'Eicosapentaenoic acid (EPA), one of the major components of fish oil, accounted for less than 0.29% of retinal lipids.'ÃÂ
'Our results support the potential value of interventions to increase retinal [very long chain polyunsaturated fatty acids] and to decrease n-6/n-3 ratios in the prevention and treatment of AMD,'ÃÂ concluded the researchers.
An abstract and the full study can be read here.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.